Anti-receptor activator of nuclear factor κB ligand antibody treatment increases osteoclastogenesis-promoting IL-8 in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

Anti-receptor activator of nuclear factor κB ligand antibody treatment increases osteoclastogenesis-promoting IL-8 in patients with rheumatoid arthritis

Published:2019-02-08 Issue:5 Volume:31 Page:277-285
ISSN:1460-2377
Container-title:International Immunology
language:en
Short-container-title:

Author:

Morita Takayoshi¹²,Shima Yoshihito¹,Fujimoto Kosuke¹³⁴,Tsuboi Hideki⁵⁶,Saeki Yukihiko⁶,Narazaki Masashi¹,Ogata Atsushi¹⁷,Kumanogoh Atsushi¹²

Affiliation:

1. Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Yamadaoka, Suita, Osaka, Japan

2. Laboratory of Immunopathology, World Premier International Immunology Frontier Research Center, Suita City, Osaka, Japan

3. Department of Immunology and Genomics, Osaka City University Graduate School of Medicine, Osaka City, Japan

4. Division of Innate Immune Regulation, International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, The University of Tokyo, Minato-Ku, Tokyo, Japan

5. Department of Orthopedic Surgery, Osaka Rosai Hospital, Sakai City, Osaka, Japan

6. Department of Clinical Research, National Hospital Organization Osaka Minami Medical Center, Kawachinagano City, Osaka, Japan

7. Division of Allergy, Rheumatology and Connective Tissue Disease, NTT West Osaka Hospital, Osaka City, Osaka, Japan

Funder

Center of Innovation Program

Ministry of Education, Culture, Sports, Science, and Technology of Japan

Grand-in-Aid for Scientific Research

Japan Society for the Promotion of Science (JSPS KAKENHI

Ministry of Health, Labor, and Welfare

Core Research for Evolutionary Science and Technology (CREST

Japan Science and Technology Agency

Publisher

Oxford University Press (OUP)

Subject

Immunology,General Medicine,Immunology and Allergy

Link

http://academic.oup.com/intimm/article-pdf/31/5/277/28532354/dxz009.pdf

Reference35 articles.

1. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis;Manolagas;Endocr. Rev,2000

2. Metastasis to bone: causes, consequences and therapeutic opportunities;Mundy;Nat. Rev. Cancer,2002

3. Denosumab for prevention of fractures in postmenopausal women with osteoporosis;Cummings;N. Engl. J. Med,2009

4. Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion;Steger;Ther. Adv. Med. Oncol,2011

5. Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways;Tanaka;World J. Orthop,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments;International Journal of Molecular Sciences;2024-07-26

2. Potential anti-osteoclastic and anti-inflammatory effects of metformin-encapsulated hyaluronic acid-decorated niosome nanoparticles: possible application for effective treatment of rheumatoid arthritis;2024-07-25

3. The role of TRPV1 in RA pathogenesis: worthy of attention;Frontiers in Immunology;2023-09-08

4. Early osteoimmunomodulation by mucin hydrogels augments the healing and revascularization of rat critical-size calvarial bone defects;Bioactive Materials;2023-07

5. Effects of oxidized soybean oil on the performance of sows and jejunum health of suckling piglets;Journal of Animal Physiology and Animal Nutrition;2022-10-12